IRIS Accounts Production v25.4.0.155 11901341 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false true false Ordinary 1.00000 Ordinary A 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 11901341 2023-06-30 11901341 2024-06-30 11901341 2023-07-01 2024-06-30 11901341 2022-06-30 11901341 2022-07-01 2023-06-30 11901341 2023-06-30 11901341 ns15:EnglandWales 2023-07-01 2024-06-30 11901341 ns14:PoundSterling 2023-07-01 2024-06-30 11901341 ns10:Director1 2023-07-01 2024-06-30 11901341 ns10:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 11901341 ns10:SmallEntities 2023-07-01 2024-06-30 11901341 ns10:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 11901341 ns10:SmallCompaniesRegimeForDirectorsReport 2023-07-01 2024-06-30 11901341 ns10:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 11901341 ns10:FullAccounts 2023-07-01 2024-06-30 11901341 ns10:OrdinaryShareClass1 2023-07-01 2024-06-30 11901341 ns10:OrdinaryShareClass2 2023-07-01 2024-06-30 11901341 ns10:Director2 2023-07-01 2024-06-30 11901341 ns10:RegisteredOffice 2023-07-01 2024-06-30 11901341 ns5:CurrentFinancialInstruments 2024-06-30 11901341 ns5:CurrentFinancialInstruments 2023-06-30 11901341 ns5:ShareCapital 2024-06-30 11901341 ns5:ShareCapital 2023-06-30 11901341 ns5:CapitalRedemptionReserve 2024-06-30 11901341 ns5:CapitalRedemptionReserve 2023-06-30 11901341 ns5:RetainedEarningsAccumulatedLosses 2024-06-30 11901341 ns5:RetainedEarningsAccumulatedLosses 2023-06-30 11901341 ns5:CostValuation 2023-06-30 11901341 ns5:UnlistedNon-exchangeTraded ns5:CostValuation 2023-06-30 11901341 ns5:AdditionsToInvestments 2024-06-30 11901341 ns5:AdditionsToInvestments ns5:UnlistedNon-exchangeTraded 2024-06-30 11901341 ns5:DisposalsRepaymentsInvestments 2024-06-30 11901341 ns5:UnlistedNon-exchangeTraded ns5:DisposalsRepaymentsInvestments 2024-06-30 11901341 ns5:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-06-30 11901341 ns5:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments ns5:UnlistedNon-exchangeTraded 2024-06-30 11901341 ns5:CostValuation 2024-06-30 11901341 ns5:UnlistedNon-exchangeTraded ns5:CostValuation 2024-06-30 11901341 ns5:UnlistedNon-exchangeTraded 2024-06-30 11901341 ns5:UnlistedNon-exchangeTraded 2023-06-30 11901341 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-06-30 11901341 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2023-06-30 11901341 ns10:OrdinaryShareClass1 2024-06-30 11901341 ns10:OrdinaryShareClass2 2024-06-30

REGISTERED NUMBER: 11901341 (England and Wales)

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2024

FOR

PAIN MEDICAL LIMITED

PAIN MEDICAL LIMITED (REGISTERED NUMBER: 11901341)

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2024

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 4 |

PAIN MEDICAL LIMITED

COMPANY INFORMATION

FOR THE YEAR ENDED 30 JUNE 2024

| DIRECTORS: | S D Dechan

| K Dechan

| REGISTERED OFFICE: | 55 Loudoun Road

| St John's Wood

| London

| NW8 0DL

| REGISTERED NUMBER: | 11901341 (England and Wales)

| ACCOUNTANTS: | MGR Weston Kay LLP

| Chartered Accountants

| 55 Loudoun Road

| St John's Wood

| London

| NW8 0DL

PAIN MEDICAL LIMITED (REGISTERED NUMBER: 11901341)

BALANCE SHEET

30 JUNE 2024

| 30.6.24 |  | 30.6.23

| Notes | £ | £ |

FIXED ASSETS

Investments | 4 | 2,117,700 |  | 2,117,775 |  |

CURRENT ASSETS

Stocks | 3,000 |  | - |  |

Debtors | 5 | 635,492 |  | 842,228 |  |

Cash at bank | 1,123 |  | 641 |  |

639,615 |  | 842,869 |  |

CREDITORS

Amounts falling due within one year | 6 | (4,823,228 | ) | (4,593,133 | ) |

NET CURRENT LIABILITIES | (4,183,613 | ) | (3,750,264 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | (2,065,913 | ) | (1,632,489 | ) |

CAPITAL AND RESERVES

Called up share capital | 7 | 60 |  | 60 |  |

Capital redemption reserve | 40 |  | 40 |  |

Retained earnings | (2,066,013 | ) | (1,632,589 | ) |

SHAREHOLDERS' FUNDS | (2,065,913 | ) | (1,632,489 | ) |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PAIN MEDICAL LIMITED (REGISTERED NUMBER: 11901341)

BALANCE SHEET - continued

30 JUNE 2024

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 February 2026 and were signed on its behalf by:

S D Dechan - Director

PAIN MEDICAL LIMITED (REGISTERED NUMBER: 11901341)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2024

1. | STATUTORY INFORMATION

| Pain Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Going Concern

| The financial statements have been prepared on the going concern basis, as the director has confirmed that funds will continue to be made available to the company from related undertakings to enable it to meet its day to day commitments for the foreseeable future. The financial statements do not include any adjustments that might result from the withdrawal of this support and the director is of the opinion that the going concern basis is appropriate to the preparation of these financial statements.

| Turnover

| Turnover represents fees receivable for the provision of veterinary medical supplies, excluding discounts, value added tax and other sales taxes.

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 2 (2023 - 2 ) .

PAIN MEDICAL LIMITED (REGISTERED NUMBER: 11901341)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30 JUNE 2024

4. | FIXED ASSET INVESTMENTS

| Shares in |

| group |  | Unlisted |

| undertakings |  | investments |  | Totals

£ | £ | £ |

| COST

| At 1 July 2023 | 175 |  | 2,117,600 |  | 2,117,775 |  |

| Additions | 100 |  | - |  | 100 |  |

| Disposals | (75 | ) | - |  | (75 | ) |

| Impairments | (100 | ) | - |  | (100 | ) |

| At 30 June 2024 | 100 |  | 2,117,600 |  | 2,117,700 |  |

| NET BOOK VALUE

| At 30 June 2024 | 100 |  | 2,117,600 |  | 2,117,700 |  |

| At 30 June 2023 | 175 |  | 2,117,600 |  | 2,117,775 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 30.6.24 |  | 30.6.23

£ | £ |

| Amounts owed by related parties | 599,864 |  | 813,676 |  |

| Other debtors | 35,628 |  | 28,552 |  |

635,492 |  | 842,228 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 30.6.24 |  | 30.6.23

£ | £ |

| Trade creditors | 10,815 |  | - |  |

| Amounts owed to related parties | 4,786,303 |  | 4,581,534 |  |

| Taxation and social security | 18,656 |  | 6,599 |  |

| Other creditors | 7,454 |  | 5,000 |  |

4,823,228 |  | 4,593,133 |  |

7. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 30.6.24 |  | 30.6.23

| value: | £ | £ |

| 50 | Ordinary | 1 | 50 |  | 50 |  |

| 10 | Ordinary A | 1 | 10 |  | 10 |  |

60 |  | 60 |  |

PAIN MEDICAL LIMITED (REGISTERED NUMBER: 11901341)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30 JUNE 2024

8. | RELATED PARTY DISCLOSURES

| Amounts owed by directors

| Advances were made to the directors during the year totalling £1,910 (2023: £19,179).

| The balance due from directors at the year end is £21,463 (2023: £19,553).